Patent · US Active

Antimicrobial compounds

US9108978B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

MONASH UNIVERSITY · AU
ADELAIDE RESEARCH & INNOVATION PTY LTD · AU

Inventors

Andrew David Abell · Christchurch, NZ
Steven Polyak · Adelaide, AU
Grant Booker · Adelaide, AU
John C. Wallace · Adelaide, AU
Tatiana Soares da Costa · Melbourne, AU
Angie Jarrad · Adelaide, AU
William Tieu · Adelaide, AU
Kelly Lee Keeling · Adelaide, AU
Daniel Sejer Pedersen · Copenhagen, DK
Nicole Pendini · Clayton, AU
Matthew Wilce · Melbourne, AU
Min Yin Yap · Melbourne, AU

Key dates

Filing date	Sep 21, 2012
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Sep 21, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/167
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.